Search hospitals > Nevada > Las Vegas
Summerlin Hospital Medical Center
Claim this profileLas Vegas, Nevada 89144
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Leukemia
Conducts research for Recurrence
Conducts research for Lymphoma
233 reported clinical trials
2 medical researchers
Summary
Summerlin Hospital Medical Center is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Cancer, Tumors, Leukemia, Recurrence, Lymphoma and other specialties. Summerlin Hospital Medical Center is involved with conducting 233 clinical trials across 493 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
148 reported clinical trials
226 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Tumors
Expert in Leukemia
52 reported clinical trials
109 drugs studied
Clinical Trials running at Summerlin Hospital Medical Center
Breast Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Bladder Carcinoma
Osteosarcoma
Gastric Cancer
Tumors
Germ Cell Tumors
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Summerlin Hospital Medical Center?
Summerlin Hospital Medical Center is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Cancer, Tumors, Leukemia, Recurrence, Lymphoma and other specialties. Summerlin Hospital Medical Center is involved with conducting 233 clinical trials across 493 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.